Prasterone phosphocholineAlternative Names: dehydroepiandrosterone phosphocholine; DHEA phosphocholine
Latest Information Update: 11 Sep 2003
At a glance
- Originator SuperGen
- Mechanism of Action Cell differentiation stimulants; Cytokine inhibitors; DNA-directed RNA polymerase stimulants; Immunosuppressants; Intercellular signalling peptide and protein stimulants; Interleukin 2 stimulants; Protein synthesis stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 12 Jul 2001 Preclinical development for Type-2 diabetes mellitus in USA (Unknown route)